| abstract |
An object of the present invention is to provide an aqueous suspension containing a glucocorticoid compound as an active ingredient. Specifically, an object of the present invention is to provide a practical pharmaceutical composition containing a glucocorticoid compound as an active ingredient. The present invention provides aqueous suspensions, pharmaceutical compositions for parenteral administration, injections, eye drops or ear drops containing the aqueous suspensions, wherein the aqueous suspensions contain nanoparticles of glucocorticoid compounds and are dispersed stably The average particle diameter of the nanoparticles is 300 nm or less and the D90 particle diameter is 450 nm or less. More specifically, the present invention provides eye drops for treating or preventing inflammatory diseases of the eye, or ear drops for treating or preventing inflammatory diseases of the ear. |